- 1Q24 revenues of $604.0 million
- 1Q24 net income of $68.5 million, adjusted EBITDA(1) of $115.2
million
- 1Q24 diluted GAAP EPS of $0.75, non-GAAP(1) EPS of $0.76
- Announced expansion of Cambridge manufacturing plant; enhancing
capabilities to serve the global CANDU and Small Modular Reactor
markets
- Reaffirms 2024 non-GAAP EPS(1) guidance of $3.05-$3.20
BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the
"Company") reported first quarter 2024 results. A reconciliation of
non-GAAP results are detailed in Exhibit 1.
"We started 2024 with solid operating results in each of our
business segments, both financially and strategically,” said Rex.
D. Geveden, president and chief executive officer. “We continued to
see good organic revenue growth across our business in the first
quarter with profitability tracking well given the significant
onboarding of new team members and the programs we are executing to
address our customers’ expanding missions.”
“BWXT’s strong employee base, technical expertise and unmatched
infrastructure position us well to benefit from the increased use
of nuclear technologies across global security, clean energy and
medical markets,” said Geveden. “Our recent announcement to expand
capacity at our Cambridge manufacturing facility not only enhances
our position in the global CANDU large reactor and advanced small
reactor markets, but also highlights the robust growth
opportunities we see in commercial nuclear power as our customers
seek to extend the life of existing power generation capacity and
add new capacity with clean baseload power.”
“We are reaffirming our 2024 financial guidance and remain
focused on operational excellence, innovation and providing our
customers with nuclear technologies as we drive toward achieving
the medium-term financial targets we provided at our recent
Investor Day,” continued Geveden.
Financial Results Summary
Three Months Ended March
31,
2024
2023
$ Change
% Change
(Unaudited) (In
millions, except per share amounts)
Revenues
Government Operations
$
487.1
$
459.9
$
27.2
6
%
Commercial Operations
$
117.0
$
108.9
$
8.1
7
%
Consolidated
$
604.0
$
568.4
$
35.6
6
%
Operating Income
Government Operations
$
85.7
$
90.6
$
(4.9
)
(5
)%
Commercial Operations
$
8.6
$
1.5
$
7.1
468
%
Unallocated Corporate (Expense)
$
(1.3
)
$
(4.2
)
$
2.9
NM
Consolidated
$
93.0
$
87.8
$
5.1
6
%
Consolidated non-GAAP(1)
$
94.6
$
91.7
$
2.9
3
%
EPS (Diluted)
GAAP
$
0.75
$
0.67
$
0.08
12
%
Non-GAAP(1)
$
0.76
$
0.70
$
0.06
9
%
Net Income
GAAP
$
68.5
$
61.0
$
7.5
12
%
Non-GAAP(1)
$
69.8
$
64.0
$
5.7
9
%
Adjusted EBITDA(1)
Government Operations
$
99.9
$
103.6
$
(3.7
)
(4
)%
Commercial Operations
$
13.9
$
8.9
$
5.0
55
%
Corporate
$
1.3
$
(1.8
)
$
3.2
NM
Consolidated
$
115.2
$
110.7
$
4.4
4
%
Cash Flows
Operating Cash Flow(2)
$
33.0
$
(13.0
)
$
46.1
NM
Capital Expenditures(2)
$
30.4
$
29.8
$
0.6
2
%
Free Cash Flow(1)
$
2.6
$
(42.8
)
$
45.4
NM
Share Repurchases(2)
$
20.0
$
—
$
20.0
NM
Dividends Paid(2)
$
22.4
$
21.7
$
0.7
3
%
NM = Not Meaningful
(2) Items named in the Financial Results
Summary differ from names in BWXT Financial Statement. Operating
Cash Flow = Net Cash Provided by Operating Activities; Capital
Expenditures = Purchases of Property, Plant and Equipment; Share
Repurchases = Repurchases of Common Stock; Dividends Paid =
Dividends Paid to Common Shareholders
Revenues
First quarter revenue increased in both operating segments. The
Government Operations increase was driven by higher naval nuclear
component production, microreactors and special materials
processing, which was partially offset by lower long-lead material
procurement. The Commercial Operations increase was driven by
higher revenue associated with commercial nuclear field services as
well as higher medical sales, which was partially offset by lower
fuel handling and components volume.
Operating Income and Adjusted EBITDA(1)
First quarter operating income increased, driven by higher
operating income in Commercial Operations and lower corporate
expense that was partially offset by lower operating income in
Government Operations. The Government Operations decrease was due
to the increase in staffing levels and associated training and
related inefficiencies, as well as mix due to higher microreactors
revenue. The Commercial Operations increase was due to improved
margin in medical, but partially offset by a less favorable product
mix in commercial nuclear. Additionally, corporate expense was
lower, mainly due to the timing of healthcare related costs.
First quarter adjusted EBITDA(1) increased for the reasons noted
above.
EPS
First quarter GAAP EPS increased due to higher operating income,
higher other income, lower interest expense and a lower effective
tax rate compared to first quarter 2023. Non-GAAP EPS(1) increased
driven by the items noted above.
Cash Flows
First quarter operating cash flow increased due to higher net
income and improved working capital management. Capital
expenditures were slightly higher due to capital expenditures
related to the timing of select growth investments.
Dividend
BWXT paid $22.4 million, or $0.24 per common share, to
shareholders in the first quarter of 2024. On May 2, 2024, the BWXT
Board of Directors declared a quarterly cash dividend of $0.24 per
common share payable on June 6, 2024, to shareholders of record on
May 17, 2024.
2024 Guidance
BWXT reaffirmed all components of its 2024 financial
guidance.
(In millions, except per share
amounts)
Year Ended
Year Ending
December 31, 2023
December 31, 2024
Results
Guidance
Revenue
$2,496
>$2,600
Adjusted EBITDA(1)
$472
~$500
Non-GAAP(1) Earnings Per Share
$3.02
$3.05 - $3.20
Free Cash Flow(1)
$212
$225 - $250
Additional information can be found in the first quarter 2024
earnings call presentation on the BWXT investor relations website
at www.bwxt.com/investors. The Company does not provide GAAP
guidance because it is unable to reliably forecast most of the
items that are excluded from GAAP to calculate non-GAAP results.
These items could cause GAAP results to differ materially from
non-GAAP results.
Conference Call to Discuss First
Quarter 2024 Results
Date:
Monday, May 6, 2024, at 5:00 p.m. EDT
Live Webcast:
Investor Relations section of website at
www.bwxt.com
Full Earnings Release Available on BWXT Website
A full version of this earnings release is available on our
Investor Relations website at
http://investors.bwxt.com/1Q2024-release.
BWXT may use its website (www.bwxt.com) as a channel of
distribution of material Company information. Financial and other
important information regarding BWXT is routinely accessible
through and posted on our website. In addition, you may elect to
automatically receive e-mail alerts and other information about
BWXT by enrolling through the “Email Alerts” section of our website
at http://investors.bwxt.com.
Non-GAAP Measures
BWXT uses and makes reference to adjusted EBITDA, non-GAAP EPS,
free cash flow and free cash flow conversion, which are not
recognized measures under GAAP. BWXT is providing these non-GAAP
measures to supplement the results provided in accordance with GAAP
and it should not be considered superior to, or as a substitute
for, the comparable GAAP measures. BWXT believes the non-GAAP
measures provide meaningful insight and transparency into the
Company’s operational performance and provides these measures to
investors to help facilitate comparisons of operating results with
prior periods and to assist them in understanding BWXT's ongoing
operations. Definitions for the non-GAAP measures are provided
below and reconciliations are detailed in Exhibit 1, except that
reconciliations of forward-looking GAAP measures are not provided
because the company is unable to reliably forecast most of the
items that are excluded from GAAP to calculate non-GAAP results.
Other companies may define these measures differently or may
utilize different non-GAAP measures, thus impacting
comparability.
Non-GAAP Earnings Per Share (EPS) is calculated using GAAP EPS
less the non-operational tax effected per share impact of pension
& OPEB mark-to-market gains or losses and other one-time items,
such as restructuring, transformation, and acquisition-related
costs.
Adjusted Earnings Before Interest, Taxes, Depreciation and
Amortization (EBITDA) is calculated using non-GAAP net income, plus
provision for income taxes, less other – net, less interest income,
plus interest expense, plus depreciation and amortization.
Adjusted pre-tax income is non-GAAP income before provision for
income taxes.
Free Cash Flow (FCF) is calculated using net income to derive
net cash provided by (used in) operating activities less purchases
of property, plant and equipment.
Free Cash Flow conversion is free cash flow divided by net
income.
Non-GAAP Adjustments
Our GAAP financial results detailed in Exhibit 1 have been
adjusted for the following items:
Restructuring and Transformation Costs: Restructuring and
transformation related costs include restructuring charges as well
as costs associated with our efforts to optimize underlying
business processes through investments in information technology,
process improvements and the implementation of strategic actions
and initiatives which we deem to be incremental and non-recurring
in nature.
Acquisition-related Costs: Acquisition-related costs relate to
third-party professional service costs and one-time incremental
costs associated with efforts to integrate the acquired business
with our legacy operations.
Forward-Looking Statements
BWXT cautions that this release contains forward-looking
statements, including, without limitation, statements relating to
backlog, to the extent they may be viewed as an indicator of future
revenues; our plans and expectations for each of our reportable
segments, including growth opportunities and the expectations,
timing and revenue of our strategic initiatives, such as medical
radioisotopes, SMR components and recent acquisitions; disruptions
to our supply chain and/or operations, changes in government
regulations and other factors; and our expectations and guidance
for 2024 and beyond. These forward-looking statements are based on
management’s current expectations and involve a number of risks and
uncertainties, including, among other things, our ability to
execute contracts in backlog; federal budget uncertainty, the risk
of future budget cuts, the impact of continuing resolution funding
mechanisms and the debt ceiling, the potential for government
shutdowns and changing funding and acquisition priorities; the
demand for and competitiveness of nuclear products and services;
capital priorities of power generating utilities and other
customers; the timing of technology development, regulatory
approvals and automation of production; the receipt and/or timing
of government approvals; the potential recurrence of subsequent
waves or strains of COVID-19 or similar diseases; labor market
challenges, including employee retention and recruitment; adverse
changes in the industries in which we operate; and delays, changes
or termination of contracts in backlog. If one or more of these
risks or other risks materialize, actual results may vary
materially from those expressed. For a more complete discussion of
these and other risk factors, see BWXT’s filings with the
Securities and Exchange Commission, including our annual report on
Form 10-K for the year ended December 31, 2023 and subsequent Form
10-Q filings. BWXT cautions not to place undue reliance on these
forward-looking statements, which speak only as of the date of this
release, and undertakes no obligation to update or revise any
forward-looking statement, except to the extent required by
applicable law.
About BWXT
At BWX Technologies, Inc. (NYSE: BWXT), we are People Strong,
Innovation Driven. Headquartered in Lynchburg, Virginia, BWXT is a
Defense News Top 100 manufacturing and engineering innovator that
provides safe and effective nuclear solutions for global security,
clean energy, environmental restoration, nuclear medicine and space
exploration. With more than 7,800 employees, BWXT has 14 major
operating sites in the U.S., Canada and the U.K. In addition, BWXT
joint ventures provide management and operations at a dozen U.S.
Department of Energy and NASA facilities. For more information,
visit www.bwxt.com. Follow us on LinkedIn, X, Facebook and
Instagram.
(1) A reconciliation of non-GAAP results
are detailed in Exhibit 1. Additional information can be found in
the materials on the BWXT investor relations website at
www.bwxt.com/investors.
EXHIBIT
1
BWX TECHNOLOGIES, INC.
RECONCILIATION OF NON-GAAP
OPERATING INCOME AND EARNINGS PER SHARE(1)(2)(3)
(In millions, except per share
amounts)
Three Months Ended March 31,
2024
GAAP
Restructuring &
Transformation Costs
Acquisition- related
Costs
Non-GAAP
Operating Income
$
93.0
$
1.6
$
0.1
$
94.6
Other Income (Expense)
(4.6
)
—
—
(4.6
)
Income Before Provision for Income
Taxes
88.4
1.6
0.1
90.0
Provision for Income Taxes
(19.8
)
(0.4
)
(0.0
)
(20.2
)
Net Income
68.5
1.2
0.0
69.8
Net Income Attributable to Noncontrolling
Interest
(0.1
)
—
—
(0.1
)
Net Income Attributable to BWXT
$
68.5
$
1.2
$
0.0
$
69.7
Diluted Shares Outstanding
91.9
91.9
Diluted Earnings per Common Share
$
0.75
$
0.01
$
0.00
$
0.76
Effective Tax Rate
22.5
%
22.5
%
Government Operations Operating Income
$
85.7
$
—
$
—
$
85.7
Commercial Operations Operating Income
$
8.6
$
0.9
$
—
$
9.4
Unallocated Corporate Operating Income
$
(1.3
)
$
0.7
$
0.1
$
(0.5
)
Three Months Ended March 31,
2023
GAAP
Restructuring Costs
Acquisition- related
Costs
Non-GAAP
Operating Income
$
87.8
$
3.5
$
0.3
$
91.7
Other Income (Expense)
(8.2
)
—
—
(8.2
)
Income Before Provision for Income
Taxes
79.7
3.5
0.3
83.5
Provision for Income Taxes
(18.7
)
(0.7
)
(0.1
)
(19.5
)
Net Income
61.0
2.8
0.3
64.0
Net Income Attributable to Noncontrolling
Interest
0.1
—
—
0.1
Net Income Attributable to BWXT
$
61.1
$
2.8
$
0.3
$
64.1
Diluted Shares Outstanding
91.8
91.8
Diluted Earnings per Common Share
$
0.67
$
0.03
$
0.00
$
0.70
Effective Tax Rate
23.4
%
23.3
%
Government Operations Operating Income
$
90.6
$
—
$
0.3
$
90.8
Commercial Operations Operating Income
$
1.5
$
3.1
$
—
$
4.6
Unallocated Corporate Operating Income
$
(4.2
)
$
0.4
$
0.1
$
(3.7
)
EXHIBIT 1
(continued)
RECONCILIATION OF CONSOLIDATED
ADJUSTED EBITDA(1)(2)(3)
(In millions)
Three Months Ended March 31,
2024
GAAP
Restructuring &
Transformation Costs
Acquisition- related
Costs
Non-GAAP
Net Income
$
68.5
$
1.2
$
0.0
$
69.8
Provision for Income Taxes
19.8
0.4
0.0
20.2
Other – net
(4.2
)
—
—
(4.2
)
Interest Expense
9.6
—
—
9.6
Interest Income
(0.8
)
—
—
(0.8
)
Depreciation & Amortization
20.6
—
—
20.6
Adjusted EBITDA
$
113.5
$
1.6
$
0.1
$
115.2
Three Months Ended March 31,
2023
GAAP
Restructuring Costs
Acquisition- related
Costs
Non-GAAP
Net Income
$
61.0
$
2.8
$
0.3
$
64.0
Provision for Income Taxes
18.7
0.7
0.1
19.5
Other – net
(2.2
)
—
—
(2.2
)
Interest Expense
10.8
—
—
10.8
Interest Income
(0.5
)
—
—
(0.5
)
Depreciation & Amortization
19.0
—
—
19.0
Adjusted EBITDA
$
106.9
$
3.5
$
0.3
$
110.7
RECONCILIATION OF REPORTING
SEGMENT ADJUSTED EBITDA(1)(2)(3)
(In millions)
Three Months Ended March 31,
2024
Operating Income
(GAAP)
Non-GAAP
Adjustments(4)
Depreciation &
Amortization
Adjusted EBITDA
Government Operations
$
85.7
$
—
$
14.2
$
99.9
Commercial Operations
$
8.6
$
0.9
$
4.4
$
13.9
Three Months Ended March 31,
2023
Operating Income
(GAAP)
Non-GAAP
Adjustments(4)
Depreciation &
Amortization
Adjusted EBITDA
Government Operations
$
90.6
$
0.3
$
12.8
$
103.6
Commercial Operations
$
1.5
$
3.1
$
4.4
$
8.9
EXHIBIT 1
(continued)
RECONCILIATION OF CONSOLIDATED
FREE CASH FLOW(1)(2)(3)
(In millions)
Three Months Ended March 31,
2024
Net Cash Provided By Operating
Activities
$
33.0
Purchases of Property, Plant and
Equipment
(30.4
)
Free Cash Flow
$
2.6
Three Months Ended March 31,
2023
Net Cash Used In Operating Activities
$
(13.0
)
Purchases of Property, Plant and
Equipment
(29.8
)
Free Cash Flow
$
(42.8
)
(1)
Tables may not foot due to rounding.
(2)
BWXT is providing non-GAAP information
regarding certain of its historical results and guidance on future
earnings per share to supplement the results provided in accordance
with GAAP and it should not be considered superior to, or as a
substitute for, the comparable GAAP measures. BWXT believes the
non-GAAP measures provide meaningful insight and transparency into
the Company’s operational performance and provides these measures
to investors to help facilitate comparisons of operating results
with prior periods and to assist them in understanding BWXT's
ongoing operations.
(3)
BWXT has not included a reconciliation of
provided non-GAAP guidance to the comparable GAAP measures due to
the difficulty of estimating any mark-to-market adjustments for
pension and post-retirement benefits, which are determined at the
end of the year.
(4)
For Non-GAAP adjustment details, see
reconciliation of non-GAAP operating income and earnings per
share.
BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED
STATEMENTS OF INCOME
Three Months Ended March
31,
2024
2023
(Unaudited) (In thousands,
except share and per share amounts)
Revenues
$
603,966
$
568,360
Costs and Expenses:
Cost of operations
455,357
431,130
Research and development costs
1,490
2,204
Losses (gains) on asset disposals and
impairments, net
—
(6
)
Selling, general and administrative
expenses
67,361
60,835
Total Costs and Expenses
524,208
494,163
Equity in Income of Investees
13,203
13,645
Operating Income
92,961
87,842
Other Income (Expense):
Interest income
846
463
Interest expense
(9,595
)
(10,819
)
Other – net
4,165
2,188
Total Other Income (Expense)
(4,584
)
(8,168
)
Income before Provision for Income
Taxes
88,377
79,674
Provision for Income Taxes
19,843
18,681
Net Income
$
68,534
$
60,993
Net Loss (Income) Attributable to
Noncontrolling Interest
(66
)
99
Net Income Attributable to BWX
Technologies, Inc.
$
68,468
$
61,092
Earnings per Common Share:
Basic:
Net Income Attributable to BWX
Technologies, Inc.
$
0.75
$
0.67
Diluted:
Net Income Attributable to BWX
Technologies, Inc.
$
0.75
$
0.67
Shares used in the computation of earnings
per share:
Basic
91,555,384
91,503,988
Diluted
91,860,923
91,799,690
BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS
Three Months Ended March
31,
2024
2023
(Unaudited) (In
thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income
$
68,534
$
60,993
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization
20,552
19,020
Income of investees, net of dividends
(2,400
)
(5,855
)
Recognition of losses for pension and
postretirement plans
831
830
Stock-based compensation expense
4,297
3,893
Other, net
129
495
Changes in assets and liabilities, net of
effects from acquisitions:
Accounts receivable
(15,493
)
(4,268
)
Accounts payable
32,832
8,135
Retainages
(26,325
)
(33,276
)
Contracts in progress and advance billings
on contracts
(17,174
)
(27,471
)
Income taxes
17,820
3,096
Accrued and other current liabilities
(2,025
)
(9,315
)
Pension liabilities, accrued
postretirement benefit obligations and employee benefits
(27,687
)
(23,097
)
Other, net
(20,865
)
(6,204
)
NET CASH PROVIDED BY (USED IN) OPERATING
ACTIVITIES
33,026
(13,024
)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and
equipment
(30,422
)
(29,780
)
Purchases of securities
—
(1,431
)
Sales and maturities of securities
—
1,425
Other, net
99
6
NET CASH USED IN INVESTING ACTIVITIES
(30,323
)
(29,780
)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings of long-term debt
120,700
127,000
Repayments of long-term debt
(102,263
)
(48,563
)
Repurchases of common stock
(20,000
)
—
Dividends paid to common shareholders
(22,396
)
(21,667
)
Cash paid for shares withheld to satisfy
employee taxes
(6,907
)
(6,903
)
Settlements of forward contracts, net
(1,337
)
(535
)
Other, net
47
4
NET CASH (USED IN) PROVIDED BY FINANCING
ACTIVITIES
(32,156
)
49,336
EFFECTS OF EXCHANGE RATE CHANGES ON
CASH
(171
)
7
TOTAL (DECREASE) INCREASE IN CASH AND CASH
EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS
(29,624
)
6,539
CASH AND CASH EQUIVALENTS AND RESTRICTED
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
81,615
40,990
CASH AND CASH EQUIVALENTS AND RESTRICTED
CASH AND CASH EQUIVALENTS AT END OF PERIOD
$
51,991
$
47,529
SUPPLEMENTAL DISCLOSURES OF CASH FLOW
INFORMATION:
Cash paid during the period for:
Interest
$
15,461
$
8,174
Income taxes (net of refunds)
$
2,161
$
15,474
SCHEDULE OF NON-CASH INVESTING
ACTIVITY:
Accrued capital expenditures included in
accounts payable
$
6,612
$
11,824
BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE
SHEETS
ASSETS
March 31, 2024
December 31,
2023
(Unaudited) (In
thousands)
Current Assets:
Cash and cash equivalents
$
45,895
$
75,766
Restricted cash and cash equivalents
2,892
2,858
Accounts receivable – trade, net
85,024
70,180
Accounts receivable – other
12,842
16,339
Retainages
81,506
55,181
Contracts in progress
550,089
533,155
Other current assets
86,415
64,322
Total Current Assets
864,663
817,801
Property, Plant and Equipment, Net
1,231,473
1,228,520
Investments
10,034
9,496
Goodwill
294,339
297,020
Deferred Income Taxes
14,828
16,332
Investments in Unconsolidated
Affiliates
91,008
88,608
Intangible Assets
180,084
185,510
Other Assets
101,581
103,778
TOTAL
$
2,788,010
$
2,747,065
BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE
SHEETS
LIABILITIES AND STOCKHOLDERS'
EQUITY
March 31, 2024
December 31,
2023
(Unaudited) (In
thousands, except share
and per share amounts)
Current Liabilities:
Current portion of long-term debt
$
7,813
$
6,250
Accounts payable
147,841
126,651
Accrued employee benefits
40,093
64,544
Accrued liabilities – other
78,717
70,210
Advance billings on contracts
112,361
107,391
Total Current Liabilities
386,825
375,046
Long-Term Debt
1,220,809
1,203,422
Accumulated Postretirement Benefit
Obligation
18,022
18,466
Environmental Liabilities
92,221
90,575
Pension Liability
79,557
82,786
Other Liabilities
44,510
43,469
Commitments and Contingencies
Stockholders' Equity:
Common stock, par value $0.01 per share,
authorized 325,000,000 shares; issued 128,272,806 and 128,065,521
shares at March 31, 2024 and December 31, 2023, respectively
1,283
1,281
Preferred stock, par value $0.01 per
share, authorized 75,000,000 shares; No shares issued
—
—
Capital in excess of par value
210,991
206,478
Retained earnings
2,140,235
2,093,917
Treasury stock at cost, 36,864,580 and
36,537,695 shares at March 31, 2024 and December 31, 2023,
respectively
(1,387,768
)
(1,360,862
)
Accumulated other comprehensive income
(loss)
(18,519
)
(7,463
)
Stockholders' Equity – BWX Technologies,
Inc.
946,222
933,351
Noncontrolling interest
(156
)
(50
)
Total Stockholders' Equity
946,066
933,301
TOTAL
$
2,788,010
$
2,747,065
BWX TECHNOLOGIES, INC.
BUSINESS SEGMENT
INFORMATION
Three Months Ended March
31,
2024
2023
(Unaudited) (In
thousands)
REVENUES:
Government Operations
$
487,121
$
459,886
Commercial Operations
117,038
108,924
Eliminations
(193
)
(450
)
TOTAL
$
603,966
$
568,360
SEGMENT
INCOME:
Government Operations
$
85,686
$
90,560
Commercial Operations
8,591
1,513
SUBTOTAL
$
94,277
$
92,073
Unallocated Corporate
(1,316
)
(4,231
)
TOTAL
$
92,961
$
87,842
DEPRECIATION AND
AMORTIZATION:
Government Operations
$
14,234
$
12,795
Commercial Operations
4,444
4,359
Corporate
1,874
1,866
TOTAL
$
20,552
$
19,020
CAPITAL
EXPENDITURES:
Government Operations
$
16,383
$
15,268
Commercial Operations
13,344
13,951
Corporate
695
561
TOTAL
$
30,422
$
29,780
BACKLOG:
Government Operations
$
2,908,986
$
3,108,628
Commercial Operations
726,523
665,745
TOTAL
$
3,635,509
$
3,774,373
BOOKINGS:
Government Operations
$
179,413
$
52,737
Commercial Operations
62,414
145,686
TOTAL
$
241,827
$
198,423
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240506660502/en/
Investor Contact: Chase Jacobson Vice President, Investor
Relations 980-365-4300 Investors@bwxt.com Media Contact: Jud
Simmons Senior Director, Media and Public Relations 434-522-6462
hjsimmons@bwxt.com
Grafico Azioni BWX Technologies (NYSE:BWXT)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni BWX Technologies (NYSE:BWXT)
Storico
Da Dic 2023 a Dic 2024